Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 1024-1027, May 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vesselinovitch, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vesselinovitch, S. D.

The Sex-dependent Difference in the Development of Liver Tumors in Mice Administered Dimethylnitrosamine1

S. D. Vesselinovitch2

Division of Oncology, The Chicago Medical School, Institute for Medical Research, Chicago, Illinois 60612

The objectives of the present investigation were to explore the effect of the dose of dimethylnitrosamine (DMN) on the induction of tumors in various tissues and evaluate the existence of a sex difference in development of liver tumors.

DMN was injected repeatedly at 3 dose levels into (C57BL x C3H)F1 mice starting at 7 days of age. The injections were given i.p. at 3-day intervals for a total of 6 times. One, 2, or 4 µg of DMN were delivered/gm body weight at each injection. Mice were sacrificed when 66 weeks of age, at which time tumor response was evaluated.

The results showed positive dose-response relationship between the dose of DMN delivered and the incidence of hepatomas, hepatocarcinomas, lung adenomas, and hemangiomas. The majority of neoplastic lesions were seen in the liver. Males developed liver tumors with significantly greater incidence (75%) than female mice (28%), suggesting existence of a modifying effect of the sex hormone environment of the host on development of liver tumors initiated by administration of DMN to infant mice.

1 This investigation was supported through Contract PH 43-65-67 from the National Cancer Institute, NIH, USPHS.

2 Present address: Department of Radiology, University of Chicago, Chicago, Illinois 60637.

Received 4/19/68. Accepted 12/18/68.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
J. M. Bugni, T. M. Poole, and N. R. Drinkwater
The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility
Carcinogenesis, November 1, 2001; 22(11): 1853 - 1862.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
N Matsukura, T Kawachi, K Morino, H Ohgaki, T Sugimura, and S Takayama
Carcinogenicity in mice of mutagenic compounds from a tryptophan pyrolyzate
Science, July 17, 1981; 213(4505): 346 - 347.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.